Study of Lanreotide to Treat Polycystic Kidney Disease
Cardiovascular Longitudinal Evaluation & Assessment of Risk (CLEAR) Study
|3||Enrolling by invitation||
Collaborative Systematic Overview of Randomised Controlled Trials of Beta-Blockers in the Treatment of Heart Failure
A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model.
|5||Active, not recruiting||
Alternative Risk Markers in Coronary Artery Disease (ARMCAD)
† Indicates status has not been verified in more than two years